Remove Clinical Trials Remove Decriminalization Remove Law Remove Therapy
article thumbnail

DMT Therapy: Coming to a Clinic Near You?

Canna Law Blog

is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. BREAKING: City of Seattle Decriminalizes Psychedelics.

Therapy 87
article thumbnail

The “Right to Try” Psilocybin and New Drug Therapies

Canna Law Blog

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments.

Therapy 78
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

The state of the law on psychedelic substances is in flux. Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra.

Law 105
article thumbnail

MAPS: “California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction”

Cannabis Law Report

Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. However, the Assembly Appropriations Committee stripped the primary intention from the bill. Ismail Lourido Ali, J.D.

article thumbnail

Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Cannabis Law Report

The Project on Psychedelics Law and Regulation (POPLAR). The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Background.

Law 59
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Professor of Law at Harvard Law School. “By Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though.

Policy 52